close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

Strona główna・Stock List・Nektar Therapeutics
Search

Nektar Therapeutics

Closed

77.83 3.17

Strong Buy

Price update 9 kwi 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

74.64

Max

77.84

Key metrics

By Trading Economics

Income

-557K

-36M

Sales

10M

22M

EPS

-1.29

Profit margin

-165.447

Employees

63

EBITDA

10M

-19M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+52.6% upside

Dividends

By Dow Jones

Next Earnings

7 maj 2026

Market Stats

By TradingEconomics

Market Cap

209M

2.1B

Previous open

74.66

Previous close

77.83

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

0.5949 / 0.7406 Support & Resistance

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 kwi 2026, 00:00 UTC

Major News Events

ADB: Higher Energy Prices to Raise Production, Consumer Costs

DJ

Read

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects Japan GDP Growth at 0.7% in 2026, 0.6% in 2027

DJ

Read

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects South Korea GDP Growth at 1.9% in 2026, 1.9% in 2027

DJ

Read

10 kwi 2026, 00:00 UTC

Major News Events

Extent of Slowdown Hinges on Duration of MidEast Conflict, ADB Says

DJ

Read

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects India GDP Growth at 6.9% in 2026, 7.3% in 2027

DJ

Read

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects China GDP Growth at 4.6% in 2026, 4.5% in 2027

DJ

Read

10 kwi 2026, 00:00 UTC

Major News Events

ADB Pojects Australia GDP Grrowth at 2.0% in 2026, 2.9% in 2027

DJ

Read

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects Taiwan GDP Growth at 7.6% in 2026, 4.0% in 2027

DJ

Read

10 kwi 2026, 00:00 UTC

Major News Events

Geopolitical Risks Make Asia's Economic Outlook Highly Uncertain, ADB Says

DJ

Read

10 kwi 2026, 00:00 UTC

Major News Events

Asia Regional Growth Likely to Moderate in 2026-2027, ADB Says

DJ

Read

9 kwi 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

DJ

Read

9 kwi 2026, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Inflation Concerns -- Market Talk

DJ

Read

9 kwi 2026, 23:14 UTC

Market Talk

Jefferies Upbeat on Australian Miners, But Recession a Key Risk -- Market Talk

DJ

Read

9 kwi 2026, 23:14 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

9 kwi 2026, 23:07 UTC

Market Talk

Centaurus's Supply Deal with Glencore Supports Jaguar Development -- Market Talk

DJ

Read

9 kwi 2026, 22:54 UTC

Market Talk

Transurban Lacks Appeal as Higher Fuel Prices Slow Traffic -- Market Talk

DJ

Read

9 kwi 2026, 22:31 UTC

Major News Events

Trump on Truth Social: 'That Is Not the Agreement We Have!'

DJ

Read

9 kwi 2026, 22:31 UTC

Major News Events

Trump on Truth Social: 'Iran Is Doing a Very Poor Job, Dishonorable Some Would Say, of Allowing Oil to Go Through the Strait of Hormuz'

DJ

Read

9 kwi 2026, 20:57 UTC

Major News Events

U.S. Oil Prices Are Back Near $100 After Israel Keeps Up Air Strikes on Lebanon -- Barrons.com

DJ

Read

9 kwi 2026, 20:55 UTC

Earnings

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

DJ

Read

9 kwi 2026, 20:55 UTC

Earnings

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

DJ

Read

9 kwi 2026, 20:55 UTC

Earnings

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

DJ

Read

9 kwi 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

DJ

Read

9 kwi 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

9 kwi 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Blackstone Investment Positions Rowan to Continue Delivering Sustainable Data Center Capacity for World's Leading Technology Cos >BX

DJ

Read

9 kwi 2026, 20:39 UTC

Acquisitions, Mergers, Takeovers

Blackstone Blackstone Acquired Significant Minority Stake in Rowan Digital Infrastructure >BX

DJ

Read

9 kwi 2026, 20:39 UTC

Acquisitions, Mergers, Takeovers

Rowan Digital Infrastructure Announces Strategic Recapitalization

DJ

Read

9 kwi 2026, 20:25 UTC

Acquisitions, Mergers, Takeovers

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

DJ

Read

9 kwi 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Read

9 kwi 2026, 19:30 UTC

Major News Events

How Digital Currencies Have Helped Iran -- WSJ

DJ

Read

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

52.6% upside

12 Months Forecast

Average 114.57 USD  52.6%

High 151 USD

Low 68 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Based on 8 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

87.92

↓-0.94%

A

Agilent Technologies Inc

115.46

↓-1.22%

VEEV

Veeva Systems Inc

157.06

↓-5.63%

HQY

HealthEquity Inc

83.88

↑ +2.36%

TLRY

Tilray Brands Inc

6.71

↓-0.3%
help-icon Live chat